Woodstock Sterile Solutions Inc – FDA 483
Woodstock Sterile Solutions received a Form 483 with seven observations during an inspection from May 24-28, 2021, highlighting significant deficiencies in their manufacturing operations. Key issues include inadequate cleaning validation for multi-product equipment, insufficient computer system controls, and a lack of proper cross-contamination prevention for potent and biologic drug products. The report also cited failures in documentation, raw material release, equipment logbook completeness, and microbiological testing procedures.
- Product type
- drugs
- Person
ID · ffd0020d-9317-417d-b8da-14754f091811
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.